✦ LIBER ✦

Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors

✍ Scribed by Alfonso Martin-Fontecha; Federica Cavallo; Matteo Bellone; Silvia Heltai; Giandomenica Iezzi; Paola Tornaghi; Nasrin Nabavi; Guido Forni; Paolo Dellabona; Giulia Casorati

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 911 KB
Volume: 26
Category: Article
ISSN: 0014-2980
DOI: 10.1002/eji.1830260828

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vaccination of tumor cells transfected w

Vaccination of tumor cells transfected with the B7-1 (CD80) gene induces the anti-metastatic effect and tumor immunity in mice

✍ Hideki Fujii; Manabu Inobe; Fuminari Kimura; Jun Murata; Masaaki Murakami; Yasuh 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 766 KB

The present study demonstrates that the transfection of B7-I or its variant MB7-2 genes into MHC class I+ tumor cells (B 16-BL6 or K I 735-M2 melanoma) resulted in the remarkable reduction of lung metastasis caused by i.v. injection into immunocompetent syngeneic mice. However, i.v. injection of the

Interleukin-12 and B7.1 co-stimulation c

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors

✍ Laurence Zitvogel; Paul D. Robbins; Walter J. Storkus; Martha R. Clarke; Markus 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 734 KB

GM-CSF and B7-1 (CD80) co-stimulatory si

GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice

✍ Hidetoshi Sumimoto; Kenzaburo Tani; Yukoh Nakazaki; Tsuyoshi Tanabe; Hitoshi Hib 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 111 KB 👁 2 views

B7-1 (CD80) co-stimulatory molecule gene-transduced Lewis lung carcinoma (LLC) cells (LLC/B7 cells) resulted in remarkable loss of tumorigenicity in syngeneic C57BL/6 mice (87.5% rejection) compared to B7-negative, wild-type LLC (LLC/wt) cells (0% rejection). However, mice that had rejected LLC/B7 c

B7-1 and B7-2 act differentially in the

B7-1 and B7-2 act differentially in the induction of a T cell response: Their impact for a HLA-matched and HLA-mismatched anti-tumor immunotherapy

✍ Kai Kronfeld; Hinrich Abken; Barbara Seliger 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 148 KB 👁 1 views

## Abstract The efficacy of T cell‐based immunotherapy is primarily due to efficient cellular activation that requires the engagement of 2 separate signals, __i.e.__, __via__ the T cell receptor complex and __via__ co‐stimulatory molecules the prototype of which is CD28. In cellular activation, the

Induction of effective antitumor immunit

Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12

✍ Tatsuhiro Joki; Tetsuro Kikuchi; Yasuharu Akasaki; Saburo Saitoh; Toshiaki Abe; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 139 KB 👁 2 views

Although tumor-specific T lymphocytes recognize tumorassociated antigens (TAA) present on their cell surface via major histocompatibility complex (MHC) molecules, T cells require other activating signals. These are provided by costimulatory molecules, including B7-1 (CD80), B7-2 (CD86) and intercell